Anjali Pandey has served as vice president, chemistry since joining Portola in November 2003. Dr. Pandey most recently was the director, chemistry at Millennium. Prior to Millennium, Dr. Pandey was with COR, working in the area of oral GP IIb-IIIa antagonists, Receptor Tyrosine Kinase inhibitors and ADP receptor antagonists and rose to the rank of director, chemistry at COR Therapeutics. Her efforts along with her team resulted in three drugs that are currently in clinical trials, one for leukemia and two for cardiovascular indications. Dr. Pandey has published over 20 scientific articles and reviews and is a named inventor on over 15 issued U.S. patents. Dr. Pandey holds an M.S. from Indian Institute of Technology, Kanpur, India and a Ph.D. from Southern Illinois University. Dr. Pandey completed a postdoctoral fellowship in Organic Chemistry at the Stanford Research Institute. She then continued on as Organic Chemist at Stanford Research Institute, where she was Principal Investigator on grant funded from National Cancer Institute.
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
Anjali Pandey
anjali pandey hero honda glamour ad
Anjali Pandey
No comments:
Post a Comment